Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126552881 | 12655288 | 1 | I | 20160802 | 20160816 | 20160816 | EXP | SE-PFIZER INC-2016373083 | PFIZER | PAUL, C.. A RANDOMIZED COMPARISON OF DOXORUBICIN AND DOXORUBICIN-DNA IN THE TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA. LEUKEMIA AND LYMPHOMA. 1991;3(5-6):355-364 | 10.00 | YR | F | Y | 0.00000 | 20160816 | OT | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126552881 | 12655288 | 1 | PS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 45 MG/M2, COURSES 1-4 | U | 50467 | 45 | MG/M**2 | |||||||
| 126552881 | 12655288 | 2 | SS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | 30 MG/M2, 1X/DAY (ON DAY 1 ) | U | 50467 | 30 | MG/M**2 | QD | |||||||
| 126552881 | 12655288 | 3 | C | ARA-C | CYTARABINE | 1 | Intravenous (not otherwise specified) | 200 MG/M2, (DURING 6 H ON DAYS 1-5) | 0 | 200 | MG/M**2 | ||||||||
| 126552881 | 12655288 | 4 | C | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 2 MG, (ON DAY 1) | 0 | 2 | MG | ||||||||
| 126552881 | 12655288 | 5 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Intravenous bolus | 7.5 MG/M2, (ON DAYS 1-5) | 0 | 7.5 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126552881 | 12655288 | 1 | Lymphocytic leukaemia |
| 126552881 | 12655288 | 3 | Acute myeloid leukaemia |
| 126552881 | 12655288 | 4 | Acute myeloid leukaemia |
| 126552881 | 12655288 | 5 | Acute myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126552881 | 12655288 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126552881 | 12655288 | Atrial fibrillation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |